Clinical Trials Logo

Infertility Unexplained clinical trials

View clinical trials related to Infertility Unexplained.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06342856 Recruiting - Clinical trials for Infertility Unexplained

Evaluation of Treatment With Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile Men With Idiopathic Oligoasthenoteratospermia

infertility
Start date: June 15, 2023
Phase: Early Phase 1
Study type: Interventional

Evaluation of treatment with Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile men with Idiopathic Oligoasthenoteratospermia

NCT ID: NCT06174298 Recruiting - Infertility Clinical Trials

The Role of Granulocyte Colony Stimulating Factor in Embryo Transfer Outcomes

Start date: March 20, 2024
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to test the effect of granulocyte colony-stimulating factor (G-CSF, A.K.A. Filgrastim) in infertility patients undergoing in vitro fertilization (IVF) treatment. The main question it aims to answer is: Can in vitro fertilization-embryo transfer (IVF-ET) outcomes be improved by supplementing the transfer media with Granulocyte colony-stimulating factor (GCSF)? Participants will undergo their embryo transfer as per the normal clinic protocol but will be randomized to either receive the standard embryo transfer media or the GCSG-supplemented transfer media. Researchers will compare the GCSF and standard transfer media groups to see if clinical outcomes are improved (i.e., implantation rate, pregnancy, clinical pregnancy rate, live birth rate).

NCT ID: NCT05824819 Recruiting - Endometriosis Clinical Trials

Endometriosis and Peritoneal Dysbiosis

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

Endometriosis is a complex clinical syndrome that impairs many aspects of a woman's life, characterized by a chronic estrogen-dependent inflammatory process, mainly affecting the pelvic organs, with ectopic presence of tissue analogous to the uterine mucosa (endometrium). Despite intensive research in the field of etiopathogenesis, its cause has not yet been determined, and treatment remains symptomatic. Endometriosis causes two main complications, i.e. pelvic pain syndrome and infertility. In recent years, thanks to the analysis of the human microbiome, it has become possible to deepen the knowledge of the physiological and pathological interactions between microorganisms inhabiting various body areas and the host. Bacteria may enter the peritoneal cavity in the mechanism of retrograde menstruation and translocate from the intestines, and then promote the development of local and systemic inflammation, leading to the symptoms of endometriosis. The study is to determine whether the presence of a specific intestinal, peritoneal and uterine microbiome correlates with endometriosis stage and whether its presence predisposes to increased pain or infertility. Concordance or divergence of bacterial populations inhabiting the peritoneal and uterine cavities could have clinical implications, i.e. the possibility of empirical antibiotic therapy in patients undergoing only endometrial aspiration biopsy and not opting for surgical treatment.

NCT ID: NCT05693220 Recruiting - Infertility Clinical Trials

Sperm Preparation Prior to Intrauterine Insemination Study

PIoUS
Start date: February 5, 2023
Phase: N/A
Study type: Interventional

This is a randomized controlled trial comparing density gradient centrifugation and microfluidic sperm sorting in patients undergoing intrauterine insemination to evaluate cumulative pregnancy outcomes.

NCT ID: NCT05670795 Recruiting - Clinical trials for Infertility Unexplained

Comparison of Recombinant Follicle Stimulating Hormone and the Combination of Recombinant Follicle Stimulating Hormone With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The aim of study is to evaluate the results of two different protocols for ovulation induction during IUI cycles. All patients undergo IUI cycles are randomly divided in to two groups. the first group is recombinant follicle stimulating hormone and the second group is the combination of recombinant follicle stimulating hormone with clomiphene citrate.

NCT ID: NCT05599724 Recruiting - Infertility Clinical Trials

PMA-FERTITHEQUE Biocollection

FERTITHEQUE
Start date: November 11, 2022
Phase:
Study type: Observational [Patient Registry]

Creation of a patient library in Medically Assisted Procreation to allow the implementation of further research with the following objectives: - To identify new relevant biomarkers in patients who will carry a pregnancy to term - To better specify or identify new infertility risk factors - To identify new relevant biomarkers in patients with reduced ovarian reserve Four consultations are planned with biological et clinical collection.

NCT ID: NCT05506722 Recruiting - Infertility, Male Clinical Trials

Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Infertility was reported in approximately 15% of all heterozygous couples, with male factor accounting for nearly half the cases. This typically occurs due to low sperm production, sperm dysfunction, and sperm delivery obstruction. Etiology of male infertility can be attributed to many factors including acute or chronic illness, accidents, and lifestyle choices.

NCT ID: NCT04144244 Recruiting - Infertility, Male Clinical Trials

Comparison of the Effect of Microchip and Density Gradient Methods in Intrauterine Insemination Cycles

Start date: November 15, 2019
Phase: N/A
Study type: Interventional

Microfluidic chips are one of the methods of sperm separation to eliminate DNA fragmentation in sperm. It is thought that the separation of sperm by centrifugation in the classical gradient density (Percoll) method used in sperm separation in IVF and IUI cycles leads to the increase of reactive oxygen radicals in sperm and this leads to sperm DNA fragmentation. Studies comparing Percoll and microfluidic chip method in terms of sperm, embryo quality and pregnancy rates are limited. In this context, it is aimed to investigate the effect of Percoll or Microfluidic Chip Technology on the quality of sperms and embryos obtained with these sperms and their pregnancy rates prospectively.